What drove the intraday move in CGNX stock today?

The intraday move stems from a Q4 revenue beat of **$252.34 million**, EPS beat and raised guidance. Heavy volume (**4,792,062**) and analyst upgrades amplified buying interest.

How does valuation look for CGNX stock?

Valuation is elevated: market cap **$9.85 billion**, P/E **86.46**, price-to-sales **9.91**. Premiums reflect expected AI-driven growth but increase sensitivity to execution risk.

What is Meyka AI's forecast for CGNX stock?

Meyka AI's forecast model projects **$36.81** (quarter) and **$30.64** (year). That implies downside versus the current price **$58.79**. Forecasts are model-based projections and not guarantees.

What are the main risks for CGNX stock investors?

Main risks include a stretched valuation, potential AI regulatory costs, and execution on margin expansion. Insider selling and a high RSI raise short-term volatility concerns.

US Stocks

CGNX Cognex Corporation (NASDAQ) $58.79 Feb 16 2026: AI demand lifts margins

ByHuzaifa Zahoor February 17, 2026February 17, 2026

CGNX stock is trading at $58.79 intraday on 16 Feb 2026 after a Q4 beat and upbeat guidance. The company reported revenue $252.34 million and EPS $0.27, topping consensus and lifting margin expectations. Volume has surged to 4,792,062 shares versus an average of 1,946,524, showing strong active interest. Investors are now weighing elevated valuation against improving cash flow and an AI-driven product cycle.